Historique
Auteur L. MONTANARI
Documents disponibles écrits par cet auteur (34)
Ajouter le résultat à votre sélection Affiner la recherche
G. QUAGLIO ; C. PATTARO ; G. GERRA ; P. MEZZELANI ; L. MONTANARI ; D. C. DES JARLAIS ; F. LUGOBONI | 2010
Dans American Journal on Addictions (Vol.19, n°3, May-June 2010) Article : PériodiqueThe aim of this study was to assess the attitudes of Italian physicians regarding buprenorphine and its clinical use approximately 6 years after the medication was introduced into clinical practice. The sample consisted of 305 randomly selected [...]
L. MONTANARI ; B. GUARITA ; J. MOUNTENEY ; N. ZIPFEL ; R. SIMON | 2017
Dans European Addiction Research (Vol.23, n°3, July 2017) Article : PériodiqueThis paper explores European and national trends in specialised drug treatment entry for cannabis-related problems. The analysis is based on data for the years 2003-2014 from 22 European countries. Between 2003 and 2014, the overall number and p[...]
Identifying the co-occurrence of drug use and mental health disorders in the same individuals is essential for effective treatment of their drug use problems. Reviewing the available information on psychiatric co-morbidity among drug users in Eu[...]
J. ANTOINE ; N. BERNDT ; M. ASTUDILLO ; D. CAIRNS ; S. JAHR ; A. JONES ; W. KUIJPERS ; N. LLORENS ; S. LYONS ; E. MAFFLI ; N. MAGLIOCCHETTI ; M. MOLINA OLIVAS ; C. PALLE ; L. SCHWARZKOPF ; J. WISSELINK ; L. MONTANARI | 2021
Dans Addiction (Vol.116, n°5, May 2021) Article : PériodiqueAIMS: To describe cocaine treatment demand in 10 western European countries and to examine the size, direction and temporality of recent trends in the proportion of cocaine users among all clients entering treatment. DESIGN: Aggregated data col[...]
OEDT = EMCDDA ; M. TORRENS ; J. I. MESTRE-PINTO ; A. DOMINGO-SALVANY ; L. MONTANARI ; J. VICENTE | 2015
RapportThis publication looks at the co-occurrence of drug use problems and mental health disorders, taking in the theoretical background of psychiatric comorbidity, the tools for clinical diagnosis and the prevalence and clinical relevance of the prob[...]
ENGLISH : Over the last several years, many European countries have seen an increase in treatment requests from the public for cannabis use. From 1996 to 2002 demand for treatment has increased by 20%. Although several outside factors have con[...]
EMCDDA Conference on 20 years of monitoring and communicating evidence on drugs (21-22 September 2015; Lisbon) ; I. GIRAUDON ; J. MATIAS ; L. MONTANARI ; D. HEDRICH ; R. SIMON ; J. VICENTE | 2015
Document texte diversDrug use, in particular high-risk drug use, is one of the major causes of avoidable mortality among young people in Europe, both directly through overdose and indirectly through drug-related diseases, accidents, violence and suicide. The Drug-r[...]
V. A. GYARMATHY ; I. GIRAUDON ; D. HEDRICH ; L. MONTANARI ; B. GUARITA ; L. WIESSING | 2009
Dans Eurosurveillance (Vol.14, n°9, 05 March 2009) Article : PériodiqueProblem drug use in pregnancy affects a sizeable population in Europe. A literature review was carried out of articles in PubMed, European Monitoring Centre for Drugs and Drug Addiction publications, and related documents in order to assess publ[...]
The report presents a review of tools for monitoring illicit drug use in prison population in Europe. The objective of the report is to describe the existing tools used at national level, to assess their comparability and to build a common Europ[...]
OEDT = EMCDDA ; A. SARASA-RENEDO ; G. BARRIO ; L. MONTANARI ; B. GUARITA ; L. DE LA FUENTE ; M. J. BRAVO ; J. VICENTE | 2015
RapportFRANÇAIS : Ce rapport décrit les tendances en matière d'injection de drogues dans les États membres de l'UE, la Norvège et la Turquie entre 2000 et 2011, à travers une analyse des données relatives aux personnes recevant un traitement médicamen[...]
This is a first common questionnaire on drug use among prisoners at European level. The questionnaire is the results of two years of work in the field of drugs and prison, which has included the agreement on a methodological framework or monitor[...]
This is the final version of the questionnaire on drug use among prisoners at European level. The questionnaire is the results of several years of work in the field of drugs and prison, which has included the agreement on a methodological framew[...]
L. MONTANARI ; M. SERAFINI ; E. MAFFLI ; M. BUSCH ; K. KONTOGEORGIOU ; W. KUIJPERS ; A. OUWEHAND ; M. POULOUDI ; R. SIMON ; M. SPYROPOULOU ; B. STUDNICKOVA ; V. A. GYARMATHY | 2011
Dans Drugs: Education, Prevention and Policy (Vol.18, n°1, February 2011) Article : PériodiqueAims: To assesses the extent of the gender gap among the treated population of drug users across Europe. Methods: This analysis reports data on 363,170 clients from 4647 treatment units in 23 countries (22 European Union member states and Switze[...]
OEDT = EMCDDA ; J. MOUNTENEY ; M. RUIZ ; A. BO ; T. GROSHKOVA ; J. MATIAS ; L. VANDAM ; F. CARDOSO ; R. CHRISTIE ; L. MONTANARI ; I. GIRAUDON ; P. GRIFFITHS | 2017
RapportThis report provides a first look at the emergence of more problematic forms of use of new psychoactive substances among a range of demographic groups, including opioid and amphetamine injectors, prisoners, the homeless and men who have sex with[...]
OEDT = EMCDDA ; A. PIRONA ; L. MONTANARI ; I. GIRAUDON ; J. MATIAS ; K. OIEN ; L. VANDAM ; T. SURMONT ; B. GUARITA ; F. MATHIS ; J. MOUNTENEY ; K. NATONIEWSKA ; S. SLEIMAN ; P. GRIFFITHS | 2021
RapportSince early 2020, the COVID-19 pandemic has had a dramatic impact on the way we live, with European countries having to introduce unprecedented measures to protect public health. As with all areas of life, drug consumption, related harms and dru[...]
